Loading…
Aakaar Medical Technologies (AAKAAR)₹70.75−4.65%Personal Care
In the Mar 2026 quarter (standalone), Aakaar Medical Technologies reported sales of ₹41.79 Cr, up 22.9% from Mar 2025, and net profit of ₹7.44 Cr, up 33.1% year on year. For the year to Mar 2026, sales were ₹67.20 Cr and net profit ₹6.66 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|
| Sales | 34.01 | 25.40 | 41.79 |
| Expenses | 25.48 | 25.46 | 31.11 |
| Operating Profit | 8.36 | −0.24 | 10.44 |
| OPM % | 24.6% | −0.9% | 25.0% |
| Other Income | 0.10 | 0.29 | 0.62 |
| Interest | 0.92 | 1.05 | 0.77 |
| Depreciation | 0.06 | 0.04 | 0.07 |
| Profit before tax | 7.49 | −1.03 | 10.23 |
| Tax % | 25.6% | −23.5% | 27.4% |
| Net Profit | 5.59 | −0.79 | 7.44 |
| EPS (Rs) | 5.32 | −0.54 | 5.22 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 22.96 | 12.47 | 19.53 | 32.91 | 46.24 | 61.82 | 67.20 |
| Expenses | 19.94 | 11.50 | 17.01 | 29.15 | 40.96 | 51.70 | 56.44 |
| Operating Profit | 2.89 | 0.91 | 2.41 | 3.54 | 5.01 | 9.78 | 10.34 |
| OPM % | 12.6% | 7.2% | 12.3% | 10.8% | 10.8% | 15.8% | 15.4% |
| Other Income | 0.11 | 0.11 | 0.03 | 0.08 | 0.15 | 0.17 | 0.79 |
| Interest | 0.47 | 0.24 | 0.22 | 0.44 | 1.15 | 1.72 | 1.81 |
| Depreciation | 0.03 | 0.02 | 0.01 | 0.08 | 0.13 | 0.11 | 0.12 |
| Profit before tax | 2.51 | 0.77 | 2.22 | 3.11 | 3.89 | 8.13 | 9.20 |
| Tax % | 26.9% | 29.0% | 26.3% | 30.7% | 26.4% | 25.7% | 27.9% |
| Net Profit | 1.84 | 0.55 | 1.63 | 2.16 | 2.88 | 6.05 | 6.66 |
| EPS (Rs) | 182.36 | 53.83 | 23.04 | 30.60 | 40.83 | 5.77 | 4.67 |
| Dividend payout % | 0.0% | 0.0% | 34.5% | 24.4% | 0.0% | 0.0% | 0.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.11 | 0.11 | 0.71 | 0.71 | 0.71 | 10.44 | 14.18 |
| Reserves | 6.78 | 7.33 | 7.35 | 9.00 | 11.89 | 12.89 | 40.48 |
| Borrowings | 5.87 | 3.87 | 3.81 | 5.85 | 15.02 | 22.70 | 18.47 |
| Other Liabilities | 3.54 | 3.03 | 6.13 | 7.69 | 6.41 | 8.21 | 6.31 |
| Total Liabilities | 16.30 | 14.34 | 18.00 | 23.25 | 34.03 | 54.24 | 79.44 |
| Fixed Assets | 0.07 | 0.05 | 0.21 | 0.37 | 0.29 | 0.25 | 0.30 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.39 |
| Investments | 0.48 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 15.75 | 14.17 | 17.79 | 22.88 | 33.74 | 53.99 | 78.75 |
| Inventories | 5.89 | 6.27 | 6.98 | 11.23 | 14.14 | 14.51 | 19.69 |
| Trade receivables | 7.40 | 4.64 | 5.58 | 10.25 | 16.29 | 28.04 | 37.33 |
| Cash & equivalents | 0.13 | 2.81 | 2.26 | 0.18 | 0.29 | 5.53 | 16.20 |
| Total Assets | 16.30 | 14.34 | 18.00 | 23.25 | 34.03 | 54.24 | 79.44 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | −0.39 | 4.32 | 0.49 | −2.94 | −8.07 | −5.42 | −8.38 |
| Cash from investing activity | 0.09 | 0.36 | −0.22 | −0.31 | −0.03 | −0.04 | 0.04 |
| Cash from financing activity | 0.27 | −1.99 | −0.80 | 1.18 | 8.20 | 10.72 | 18.81 |
| Net cash flow | 0.00 | 2.69 | −0.56 | −2.09 | 0.12 | 5.26 | 10.50 |
| Capex | 0.01 | 0.00 | 0.18 | 0.25 | 0.04 | 0.07 | 0.57 |
| Free cash flow | −0.39 | 4.29 | 0.28 | −3.18 | −8.06 | −5.47 | −8.90 |
| CFO / OP % | 10.0% | 503.1% | 47.0% | −54.0% | −136.0% | −35.0% | −59.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 119 | 137 | 105 | 115 | 130 | 167 | 204 |
| Inventory days | 234 | 366 | 282 | 274 | 247 | 202 | 256 |
| Days payable | 28 | 99 | 65 | 62 | 32 | 49 | 24 |
| Cash conversion cycle | 324 | 403 | 321 | 326 | 344 | 320 | 434 |
| Working capital days | 190 | 239 | 106 | 103 | 95 | 98 | 200 |
| ROCE % | — | 8.2% | 20.9% | 25.8% | 23.3% | 26.7% | 18.4% |
For the Mar 2026 quarter, Aakaar Medical Technologies reported sales of ₹41.79 Cr, up 22.9% year on year and net profit of ₹7.44 Cr, up 33.1% year on year. The operating margin was 25.0%.
Aakaar Medical Technologies' sales for the year to Mar 2026 were ₹67.20 Cr.
Net profit for the year to Mar 2026 was ₹6.66 Cr. Earnings per share over the same trailing period were ₹4.67.
Aakaar Medical Technologies reported borrowings of ₹18.47 Cr at Mar 2026, against cash and equivalents of ₹16.20 Cr.
Cash from operations was −₹8.38 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹8.90 Cr.